Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
MultiCare Pulmonary Specialists
mi
from
Tacoma, WA
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
MultiCare Pulmonary Specialists
mi
from
Tacoma, WA
Click here to add this to my saved trials
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
Franciscan Research Center (St. Joseph Medical Center)
mi
from
Tacoma, WA
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
Franciscan Research Center (St. Joseph Medical Center)
mi
from
Tacoma, WA
Click here to add this to my saved trials
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
HealthPartners Specialty Center, Lung and Sleep Health
mi
from
Saint Paul, MN
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
HealthPartners Specialty Center, Lung and Sleep Health
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
Surrey Memorial Hospital
mi
from
Surrey,
Bronchial Thermoplasty in Severe Persistent Asthma
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
Surrey Memorial Hospital
mi
from
Surrey,
Click here to add this to my saved trials
Improving Parent Understanding of Instructions About Asthma Care
Improving Parent Understanding of Instructions About Asthma Care
Status: Enrolling
Updated:  12/31/1969
NYU School of Medicine
mi
from
New York, NY
Improving Parent Understanding of Instructions About Asthma Care
Improving Parent Understanding of Instructions About Asthma Care
Status: Enrolling
Updated: 12/31/1969
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Vitamin D for Sickle-cell Respiratory Complications
Vitamin D for Sickle-cell Respiratory Complications
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Vitamin D for Sickle-cell Respiratory Complications
Vitamin D for Sickle-cell Respiratory Complications
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated:  12/31/1969
Amphastar Site 5
mi
from
Costa Mesa, CA
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated: 12/31/1969
Amphastar Site 5
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated:  12/31/1969
Amphastar Site 8
mi
from
Orange, CA
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated: 12/31/1969
Amphastar Site 8
mi
from
Orange, CA
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated:  12/31/1969
Amphastar Site 4
mi
from
Stockton, CA
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated: 12/31/1969
Amphastar Site 4
mi
from
Stockton, CA
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated:  12/31/1969
Amphastar Site 2
mi
from
Medford, OR
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated: 12/31/1969
Amphastar Site 2
mi
from
Medford, OR
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated:  12/31/1969
Amphastar Site 1
mi
from
Portland, OR
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated: 12/31/1969
Amphastar Site 1
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated:  12/31/1969
Amphastar Site 7
mi
from
North Charleston, SC
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated: 12/31/1969
Amphastar Site 7
mi
from
North Charleston, SC
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated:  12/31/1969
Amphastar Site 3
mi
from
El Paso, TX
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated: 12/31/1969
Amphastar Site 3
mi
from
El Paso, TX
Click here to add this to my saved trials
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated:  12/31/1969
Amphastar Site 6
mi
from
San Antonio, TX
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma
Status: Enrolling
Updated: 12/31/1969
Amphastar Site 6
mi
from
San Antonio, TX
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Mobile, AL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Montgomery, AL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Montgomery, AL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Scottsboro, AL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Scottsboro, AL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Toney, AL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Toney, AL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Tuscaloosa, AL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Dothan, AK
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Dothan, AK
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Chandler, AZ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Chandler, AZ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Phoenix, AZ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Scottsdale, AZ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Scottsdale, AZ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Tucson, AZ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Tucson, AZ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Bentonville, AR
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bentonville, AR
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Little Rock, AR
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Little Rock, AR
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Little Rock, AR
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Alhambra, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Alhambra, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Canoga Park, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Canoga Park, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Dinuba, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Dinuba, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Fresno, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fresno, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Fresno, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fresno, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Fresno, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fresno, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Gold River, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Gold River, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Granada Hills, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Granada Hills, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Harbor City, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Harbor City, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Huntington Beach, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Huntington Park, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Huntington Park, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Long Beach, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Long Beach, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Long Beach, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Los Angeles, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Napa, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Napa, CA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Newport Beach, CA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials